yeah not a fantastic situation. the products and the science do remain. NVS wasn't pivotal to the company's success, but its definitely a chip off the old cash flow piece.
Ann: Update on Novartis Agreement, page-50
-
- There are more pages in this discussion • 801 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.005(0.42%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.20 | $1.18 | $1.219M | 1.025M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 41382 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 260082 | 31 |
View Market Depth
| Last trade - 10.39am 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |